EmbryoSpin is the first NMR sensor capable of operation at the embryo scale. (Image: EPFL)
EmbryoSpin is the first NMR sensor capable of operation at the embryo scale. (Image: EPFL) - EPFL spin-off Annaida is developing a magnetic resonance system that can detect the chemistry inside the tiniest living organisms. The technology's initial application will be in the field of fertility treatment, where it will be used to assess the viability of embryos before implantation. The company has just raised one million Swiss francs to validate safety and efficacy of its technology. When it comes to the success of fertility treatment, selecting viable embryos can make all the difference. Scientists can already assess this tiny organism's morphology and genetic makeup, but there is currently no way to determine its internal chemistry. Yet obtaining this data would make it easier to more accurately predict the likelihood of healthy development.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
